can tirzepatide cause tachycardia Does Heart Palpitations? Clinical Evidence and Safety Tirzepatide and Cardiovascular Outcomes: A
Description
Studies published in English with treatment duration 12 weeks and information on HbA1c changes were included
Personalized Semaglutide+ from Yucca Health
Semaglutide was approved in 2017 as Ozempic for diabetes, and in 2021 as Wegovy for obesity
The patient was a 44-year-old male with severe morbid obesity, heart failure, oxygen-dependent obesity hypoventilation syndrome, uncontrolled hypertension, anemia, and depression
Same here
